Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine + BEAC in Peripheral T-cell Lymphoma
NCT04880746Phase 3Unknown
- Sponsor
- Ruijin Hospital
- Start
- Oct 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in peripheral T-cell lymphoma (PTCL), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
cladribine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT04880746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04880746.